Sedative effects and prolactin response to single oral doses of melperone
- PMID: 6133301
- DOI: 10.1007/BF00427801
Sedative effects and prolactin response to single oral doses of melperone
Abstract
The pharmacokinetics of melperone and the relationship between plasma concentration and the effect on arousal and prolactin secretion after single oral doses (10, 25, 50 and 100 mg) was studied in normal subjects. Dose-dependent kinetics were indicated by the fact that higher plasma concentrations than expected were demonstrated after the 100-mg dose. Melperone decreased arousal and increased prolactin secretion in a dose-dependent manner. The level of arousal was correlated to melperone plasma concentration over the entire dose range. Prolactin secretion was also correlated to melperone plasma concentration, provided the relationship was studied separately for the individual melperone doses. Thus at higher doses, higher plasma concentrations are needed to elicit the same prolactin outflow. The possibility that reduced arousal reactions might contribute in the antipsychotic action of neuroleptic drugs was discussed.
Similar articles
-
Relationship between plasma concentration and arousal in normal subjects after single oral and parenteral doses of melperone, a butyrophenone neuroleptic.Psychopharmacology (Berl). 1983;79(2-3):111-4. doi: 10.1007/BF00427795. Psychopharmacology (Berl). 1983. PMID: 6133299
-
Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.Hum Psychopharmacol. 2009 Jul;24(5):415-22. doi: 10.1002/hup.1036. Hum Psychopharmacol. 2009. PMID: 19551763 Clinical Trial.
-
Effect of melperone, two of its metabolites and thiothixene on central monoamine metabolism and prolactin levels in rodents.Acta Pharmacol Toxicol (Copenh). 1978 Aug;43(2):129-36. doi: 10.1111/j.1600-0773.1978.tb02246.x. Acta Pharmacol Toxicol (Copenh). 1978. PMID: 696342
-
Clinical pharmacokinetics of the depot antipsychotics.Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003. Clin Pharmacokinet. 1985. PMID: 2864156 Review.
-
[Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].Encephale. 2014 Feb;40(1):86-94. doi: 10.1016/j.encep.2012.03.002. Epub 2013 Aug 5. Encephale. 2014. PMID: 23928066 Review. French.
Cited by
-
Development of orally disintegrating tablets comprising controlled-release multiparticulate beads.Drug Dev Ind Pharm. 2012 Dec;38(12):1428-40. doi: 10.3109/03639045.2011.653365. Epub 2012 Feb 23. Drug Dev Ind Pharm. 2012. PMID: 22356215 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources